EKINOPS Valuation
Is EKI undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of EKI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: EKI (€3.93) is trading below our estimate of fair value (€8.57)
Significantly Below Fair Value: EKI is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for EKI?
Key metric: As EKI is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
| What is EKI's PS Ratio? | |
|---|---|
| PS Ratio | 0.9x |
| Sales | €115.56m |
| Market Cap | €105.95m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 0.9x |
| Enterprise Value/EBITDA | 42.8x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does EKI's PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 0.9x | ||
ALLEC Cogelec | 1.9x | 11.4% | €134.4m |
PARRO Parrot | 1.2x | n/a | €75.5m |
ATEME ATEME | 0.6x | 9.8% | €50.6m |
VANTI Vantiva | 0.03x | 5.1% | €65.7m |
EKI EKINOPS | 0.9x | 8.6% | €106.0m |
Price-To-Sales vs Peers: EKI is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (0.9x).
Price to Sales Ratio vs Industry
How does EKI's PS Ratio compare vs other companies in the European Communications Industry?
| 6 Companies | Price / Sales | Estimated Growth | Market Cap |
|---|---|---|---|
| 6 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Sales vs Industry: EKI is good value based on its Price-To-Sales Ratio (0.9x) compared to the European Communications industry average (1.1x).
Price to Sales Ratio vs Fair Ratio
What is EKI's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.9x |
| Fair PS Ratio | 0.6x |
Price-To-Sales vs Fair Ratio: EKI is expensive based on its Price-To-Sales Ratio (0.9x) compared to the estimated Fair Price-To-Sales Ratio (0.6x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €3.93 | €6.13 +56.3% | 15.9% | €7.60 | €4.50 | n/a | 6 |
| Nov ’25 | €3.95 | €5.97 +51.2% | 19.0% | €7.60 | €4.50 | n/a | 6 |
| Oct ’25 | €4.06 | €5.92 +45.7% | 20.0% | €7.60 | €4.30 | n/a | 6 |
| Sep ’25 | €3.55 | €5.57 +56.8% | 16.4% | €6.80 | €4.30 | n/a | 6 |
| Aug ’25 | €3.36 | €5.57 +65.7% | 16.4% | €6.80 | €4.30 | n/a | 6 |
| Jul ’25 | €3.44 | €6.00 +74.7% | 13.3% | €6.80 | €4.40 | n/a | 6 |
| Jun ’25 | €4.10 | €6.00 +46.3% | 13.3% | €6.80 | €4.40 | n/a | 6 |
| May ’25 | €3.30 | €6.42 +94.4% | 19.1% | €8.50 | €4.40 | n/a | 6 |
| Apr ’25 | €3.73 | €6.95 +86.3% | 20.8% | €8.50 | €4.40 | n/a | 6 |
| Mar ’25 | €3.90 | €8.12 +108.1% | 6.0% | €8.70 | €7.50 | n/a | 6 |
| Feb ’25 | €4.45 | €8.12 +82.4% | 6.0% | €8.70 | €7.50 | n/a | 6 |
| Jan ’25 | €5.86 | €8.33 +42.1% | 12.9% | €10.00 | €6.20 | n/a | 7 |
| Dec ’24 | €4.71 | €8.33 +77.0% | 12.9% | €10.00 | €6.20 | n/a | 7 |
| Nov ’24 | €4.61 | €8.64 +87.5% | 16.0% | €10.80 | €6.20 | €3.95 | 7 |
| Oct ’24 | €5.90 | €10.66 +80.6% | 8.4% | €12.00 | €9.00 | €4.06 | 7 |
| Sep ’24 | €6.98 | €10.66 +52.7% | 8.4% | €12.00 | €9.00 | €3.55 | 7 |
| Aug ’24 | €7.98 | €10.73 +34.4% | 8.0% | €12.00 | €9.00 | €3.36 | 7 |
| Jul ’24 | €7.93 | €10.84 +36.7% | 9.1% | €12.20 | €9.00 | €3.44 | 7 |
| Jun ’24 | €7.96 | €10.84 +36.2% | 9.1% | €12.20 | €9.00 | €4.10 | 7 |
| May ’24 | €8.15 | €10.87 +33.3% | 9.4% | €12.00 | €9.00 | €3.30 | 6 |
| Apr ’24 | €8.82 | €10.75 +21.9% | 10.7% | €12.00 | €9.00 | €3.73 | 6 |
| Mar ’24 | €8.73 | €10.07 +15.3% | 7.9% | €11.10 | €9.00 | €3.90 | 6 |
| Feb ’24 | €8.60 | €10.07 +17.1% | 7.9% | €11.10 | €9.00 | €4.45 | 6 |
| Jan ’24 | €8.40 | €9.88 +17.7% | 11.6% | €11.10 | €8.00 | €5.86 | 6 |
| Dec ’23 | €7.20 | €9.88 +37.3% | 11.6% | €11.10 | €8.00 | €4.71 | 6 |
| Nov ’23 | €7.10 | €9.87 +39.0% | 11.4% | €11.00 | €8.00 | €4.61 | 6 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.
Discover undervalued companies
ENENSYS Technologies
€5.0m
Engages in the design and marketing of hardware and software solutions for media distributors in France, rest of Europe, the Middle East, Africa, the Asia Pacific, North America, and Latin America.
ALNN6
€0.77
7D
-10.6%
1Y
7.2%
Broadpeak Société anonyme
€12.4m
Designs and manufactures video delivery components for content and network service providers deploying video streaming services over fixed, mobile or satellite broadband networks worldwide.
ALBPK
€1.00
7D
2.7%
1Y
-67.9%
Egide
€7.4m
Designs, manufactures, and sells hermetic packages to protect and interconnect various types of electronic or photonic chips in France, rest of the European Union, North America, and internationally.
ALGID
€0.38
7D
-9.8%
1Y
-39.5%